In 2019, they also conducted an in vivo CRISPR screen to identify membrane targets for improving immunotherapy in GBM by transducing an adeno-associated virus (AAV)-surf library into naïve CD8+ T cells and transfusing them into GBM-bearing mice (126). The gene discussed is CD8A; the disease is glioblastoma.